Research and Reports in Gynecology and Obstetrics

Oral antifungals in dermatology safety

Joint Event on International Conference on Palliative Care, Obstetrics and Gynecology & International Conference on Stroke and Clinical Trials
February 28-March 01, 2019 | Paris, France

Macarena Morales Conde

Hospital Juan Ramon Jimenez, Spain

Posters & Accepted Abstracts : Res Rep Gynaecol Obstet

DOI: 10.4066/2591-7366-C1-003

Abstract:

Oral antifungals are drugs frequently used in dermatology. They are indicated as the first line of treatment in infections such as tinea capitis or advanced onychomycosis. In addition, they may be indicated for dermatophyte or yeast infections when they are resistant to topical treatments, such as extended pityriasis versicolor. The objective of this work is to review the safety of the use of these drugs, focusing also on special situations such as pregnancy, lactation, childhood or patients with multiple pathologies.

Methods: To do this, we will review the literature in the PubMed database using the keywords “oral antifungal drugs” and “safety”. We will limit the search to the last 10 years and to those publications that ae available for full reading

Biography:

Macarena Morales Conde completed her university studies at the faculty of medicine of Seville in 2013 and finished her speciality in surgical dermatology and venereology in 2018 at the Virgen Macarena Hospital in Seville. She completed her master’s degree in clinical medical research and another in clinical dermatology. She has dozens of publications in national and international congresses, book chapters and articles in international journals. She is a member of the Spanish Academy of Dermatology and Venereology. 

E-mail: macarena.moralesconde@gmail.com

PDF HTML